743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
25.60%
Revenue growth above 1.5x BIDU's 0.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
27.94%
Gross profit growth above 1.5x BIDU's 3.61%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
43.54%
EBIT growth above 1.5x BIDU's 1.57%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
43.54%
Operating income growth above 1.5x BIDU's 1.57%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-9.27%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-9.26%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-9.43%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.03%
Share reduction while BIDU is at 0.23%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.07%
Reduced diluted shares while BIDU is at 0.38%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
25.16%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
23.67%
FCF growth similar to BIDU's 23.21%. Walter Schloss would attribute it to parallel capital spending and operational models.
853.81%
10Y revenue/share CAGR under 50% of BIDU's 3865.06%. Michael Burry would suspect a lasting competitive disadvantage.
637.34%
5Y revenue/share CAGR above 1.5x BIDU's 273.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
218.90%
3Y revenue/share CAGR above 1.5x BIDU's 69.15%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1150.68%
OCF/share CAGR of 1150.68% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
914.70%
5Y OCF/share CAGR above 1.5x BIDU's 251.56%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
358.70%
3Y OCF/share CAGR of 358.70% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1075.27%
Net income/share CAGR at 50-75% of BIDU's 1719.05%. Martin Whitman might question if the firm’s product or cost base lags behind.
8842.26%
5Y net income/share CAGR above 1.5x BIDU's 49.54%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
480.54%
3Y net income/share CAGR above 1.5x BIDU's 29.95%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1162.05%
Below 50% of BIDU's 5402.42%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
469.81%
5Y equity/share CAGR 1.25-1.5x BIDU's 344.98%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
94.99%
3Y equity/share CAGR at 75-90% of BIDU's 125.85%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.83%
Our AR growth while BIDU is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
7.00%
Asset growth above 1.5x BIDU's 3.40%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.44%
Under 50% of BIDU's 15.82%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Our R&D shrinks while BIDU invests at 14.25%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
20.75%
We expand SG&A while BIDU cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.